Flexion Therapeutics EPS beats by $0.09, beats on revenue

Aug. 06, 2019 4:08 PM ETPacira BioSciences, Inc. (PCRX)PCRXBy: Vandana Singh, SA News Editor7 Comments
  • Flexion Therapeutics (NASDAQ:FLXN): Q2 GAAP EPS of -$0.96 beats by $0.09.
  • Revenue of $16.95M (+347.2% Y/Y) beats by $1.99M.
  • Press Release
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.